Literature DB >> 19843164

Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus.

Sue-Li Dahlroth1, Daniel Gurmu, Florian Schmitzberger, Henrik Engman, Juergen Haas, Heidi Erlandsen, Pär Nordlund.   

Abstract

The Kaposi's sarcoma-associated herpesvirus protein SOX (shut off and exonuclease) and its Epstein-Barr virus homolog, BGLF5, are active during the early lytic phase and belong to the alkaline nuclease family. Both proteins have been shown to be bifunctional, being responsible for DNA maturation as well as host shutoff at the mRNA level. We present the crystal structure of SOX determined at 1.85 A resolution. By modeling DNA binding, we have identified catalytic residues that explain the preferred 5'-exonuclease activity of the alkaline nucleases. The presence of a crevice suitable for binding duplex DNA supports a role for herpes alkaline nucleases in recombination events preceding packaging of viral DNA. Direct interaction with dsDNA is supported by oligonucleotide binding data. Mutations specifically affecting host shutoff map to a surface region of the N-terminal domain, implying an essential role in protein-protein interactions, and link the RNase activity of the enzyme to mRNA degradation pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843164     DOI: 10.1111/j.1742-4658.2009.07374.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  26 in total

1.  The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection.

Authors:  Daniëlle Horst; Wim P Burmeister; Ingrid G J Boer; Daphne van Leeuwen; Marlyse Buisson; Alexander E Gorbalenya; Emmanuel J H J Wiertz; Maaike E Ressing
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

Review 2.  Diverse virus-host interactions influence RNA-based regulation during γ-herpesvirus infection.

Authors:  Lisa M Kronstad; Britt A Glaunsinger
Journal:  Curr Opin Microbiol       Date:  2012-06-09       Impact factor: 7.934

3.  Determining the Protein Stability of Alzheimer's Disease Protein, Amyloid Precursor Protein.

Authors:  Alexandré Delport; Raymond Hewer
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

4.  Crystal structures of lambda exonuclease in complex with DNA suggest an electrostatic ratchet mechanism for processivity.

Authors:  Jinjin Zhang; Kimberly A McCabe; Charles E Bell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

5.  Structural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98.

Authors:  Alison L Kuchta; Hardik Parikh; Yali Zhu; Glen E Kellogg; Deborah S Parris; Michael A McVoy
Journal:  J Gen Virol       Date:  2011-09-07       Impact factor: 3.891

Review 6.  Structure and mechanism of the Red recombination system of bacteriophage λ.

Authors:  Brian J Caldwell; Charles E Bell
Journal:  Prog Biophys Mol Biol       Date:  2019-03-21       Impact factor: 3.667

7.  Structure of the Open Reading Frame 49 Protein Encoded by Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Kelly Hew; Saranya Veerappan; Daniel Sim; Tobias Cornvik; Pär Nordlund; Sue-Li Dahlroth
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

8.  The UL12 protein of herpes simplex virus 1 is regulated by tyrosine phosphorylation.

Authors:  Hikaru Fujii; Akihisa Kato; Michio Mugitani; Yukie Kashima; Masaaki Oyama; Hiroko Kozuka-Hata; Jun Arii; Yasushi Kawaguchi
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

9.  Mitochondrial nucleases ENDOG and EXOG participate in mitochondrial DNA depletion initiated by herpes simplex virus 1 UL12.5.

Authors:  Brett A Duguay; James R Smiley
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 10.  Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity.

Authors:  Martin Rowe; Jianmin Zuo
Journal:  Microbes Infect       Date:  2010-02-01       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.